Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Yuko Oya

4PUBLICATIONS

33CO-AUTHORS

Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|Sep 16, 2024

It might be a dead end: immune checkpoint inhibitor therapy in EGFR-mutated NSCLC.

Ken Akao, Yuko Oya, Takaya Sato

|Jan 05, 2024

Phase II Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Small Cell Lung Cancer Cohort.

Makoto Nishio, Shuji Murakami, Hisato Kawakami

|Jun 09, 2021

Novel strategy to treat lung metastases: Hybrid therapy involving surgery and radiofrequency ablation.

Takaaki Hasegawa, Hiroaki Kuroda, Noriaki Sakakura

|Jul 09, 2020

Propensity score analysis of overall survival between first- and second-generation EGFR-TKIs using real-world data.

Kentaro Ito, Kenta Murotani, Akihito Kubo

Pageof 1

Frequent Collaborators

1 joint publications

Kentaro Ito

1 joint publications

Kosuke Takahashi

1 joint publications

Toyoaki Hida

1 joint publications

Takaaki Hasegawa

1 joint publications

Hiroaki Kuroda

1 joint publications

Yozo Sato

1 joint publications

Shohei Chatani

1 joint publications

Shinichi Murata

1 joint publications

Hidekazu Yamaura

1 joint publications

Takeo Nakada

Frequent Collaborators

1 joint publications

Kentaro Ito

1 joint publications

Kosuke Takahashi

1 joint publications

Toyoaki Hida

1 joint publications

Takaaki Hasegawa

Top Related Videos

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on : Feb 12, 2017

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on : May 08, 2018

See more related videos

Top Related Videos

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on : Feb 12, 2017

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on : May 08, 2018

See more related videos